Juan Carlos Garcia-Betancur
Overview
Explore the profile of Juan Carlos Garcia-Betancur including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Restrepo-Arbelaez N, Garcia-Betancur J, Pallares C, El Ayoubi L, Kiratisin P, Kanj S, et al.
Antimicrob Steward Healthc Epidemiol
. 2024 Nov;
4(1):e196.
PMID: 39563931
Antimicrobial resistance (AMR) is positioning as one of the most relevant threats to global public health and threatens the effective treatment of an ever-growing number of bacterial infections in various...
2.
De la Cadena E, Mojica M, Rojas L, Castro B, Garcia-Betancur J, Marshall S, et al.
Microbiol Spectr
. 2024 May;
12(6):e0410523.
PMID: 38700337
Importance: Latin America and the Caribbean is an endemic region for carbapenemases. Increasingly high rates of carbapenemase (KPC) have established ceftazidime-avibactam (CZA) as an essential antimicrobial for the treatment of...
3.
De la Cadena E, Pallares C, Garcia-Betancur J, Porras J, Villegas M
Biomedica
. 2023 Dec;
43(4):457-473.
PMID: 38109138
Introduction: Antimicrobial resistance surveillance is a fundamental tool for the development, improvement, and adjustment of antimicrobial stewardship programs, therapeutic guidelines, and universal precautions to limit the cross-transmission of resistant bacteria...
4.
Restrepo-Arbelaez N, Garcia-Betancur J, Pallares C, Villegas M
Antibiotics (Basel)
. 2023 Aug;
12(8).
PMID: 37627762
Antimicrobial resistance is one of the major global health threats. Antimicrobial stewardship (AMS) has been set as a priority within international action plans to combat this issue. The region of...
5.
Pallares C, Porras J, De la Cadena E, Garcia-Betancur J, Restrepo-Arbelaez N, Viveros S, et al.
BMC Infect Dis
. 2023 Jul;
23(1):463.
PMID: 37434158
Background: Studies have shown that more than 50% of the antibiotics used in hospitals are unnecessary or inappropriate and, that antimicrobial resistance may cost up to 20 billion USD in...
6.
De la Cadena E, Mahecha M, Velandia A, Garcia-Betancur J, Rojas L, Porras J, et al.
Antibiotics (Basel)
. 2023 Mar;
12(3).
PMID: 36978355
We report the presence of the gene among 880 clinical isolates collected in 13 hospitals from 12 Colombian cities between 2016 and 2019. Seven (0.8%) isolates were colistin resistant (MIC...
7.
Mojica M, De la Cadena E, Garcia-Betancur J, Porras J, Novoa-Caicedo I, Paez-Zamora L, et al.
mSphere
. 2023 Mar;
8(2):e0065122.
PMID: 36877058
Ceftazidime-avibactam (CZA) is the combination of a third-generation cephalosporin and a new non-β-lactam β-lactamase inhibitor capable of inactivating class A, C, and some D β-lactamases. From a collection of 2,727...
8.
Mojica M, De la Cadena E, Rios R, Garcia-Betancur J, Diaz L, Reyes J, et al.
Front Microbiol
. 2022 Nov;
13:1035609.
PMID: 36353456
Objectives: Identify molecular mechanisms responsible for the non-susceptibility to ceftolozane/tazobactam (TOL) in a group of 158 clinical isolates of from five Latin American countries collected before the introduction of TOL...
9.
Garcia-Betancur J, De la Cadena E, Mojica M, Hernandez-Gomez C, Correa A, Radice M, et al.
Antibiotics (Basel)
. 2022 Aug;
11(8).
PMID: 36009970
Background: Ceftolozane/tazobactam (C/T) is a combination of an antipseudomonal oxyiminoaminothiazolyl cephalosporin with potent in vitro activity against and tazobactam, a known β-lactamase inhibitor. The aim of this study was to...
10.
De la Cadena E, Mojica M, Garcia-Betancur J, Appel T, Porras J, Pallares C, et al.
Antibiotics (Basel)
. 2021 Apr;
10(3).
PMID: 33801833
Polymyxin resistance in has been attributed to mutations in , , , and and to the presence of plasmid-mediated genes. Herein, we describe the molecular characteristics of 24 polymyxin- and...